The U.S. Onychomycosis Market 2018 - Profiles for Valeant Pharmaceuticals, Pfizer, Novartis and Johnson & Johnson - ResearchAndMarkets.com

DUBLIN--()--
The "The U.S. Onychomycosis Market: Size, Trends and Forecasts (2018 Edition)" report has been added to ResearchAndMarkets.com's offering.

The U.S. onychomycosis market (prescription drugs) has increased with a healthy growth rate over the years and is expected to increase further during the forecasted period.

The U.S. onychomycosis market is supported by various growth drivers, such as rising per capita healthcare expenditure, increasing diabetic patients, ageing population, introduction of new drugs, etc. Yet, the market faces certain challenges, such as, reimbursements, low awareness, side effects, etc.

Key Topics Covered

1. Executive Summary

2. Introduction

3. Global Market Analysis

4. U.S. Market Analysis

5. Competitive Landscape

6. Company Profiles

  • Valeant Pharmaceuticals
  • Pfizer Inc.
  • Novartis AG
  • Johnson & Johnson

For more information about this report visit https://www.researchandmarkets.com/research/hcgc2m/the_u_s?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs